Globe Life upgraded to Outperform at Evercore
Evercore ISI upgraded life insurer Globe Life (NYSE:GL) to Outperform from In Line as the stock has "materially recovered" ...
Evercore ISI Keeps Their Buy Rating on Altimmune (ALT)
Evercore ISI analyst Liisa Bayko maintained a Buy rating on Altimmune (ALT – Research Report) today and set a price target of $25.00. The ...
Europe’s Automakers Face Pummeling In 2025 But Positives Remain
Europe’s automakers face existential threats from EU CO2 rules, China competition, weak sales and factory closures. The ...
Evercore’s AI enablers, adopters and adapters: CRM, MU, CI, EQT and more
Evercore ISI analysts updated their list of AI-enabling stocks from the Russell 3000 with positive earnings reactions and ...
M&A boutique firm Tidal Partners hires Evercore banker for software dealmaking
Tidal Partners, a mergers and acquisitions advisory firm launched in 2022 by former Centerview Partners dealmakers, has hired investment banker Anand Sankaralingam from Evercore , according to people ...
GE HealthCare price target lowered to $98 from $102 at Evercore ISI
Evercore ISI lowered the firm’s price target on GE HealthCare (GEHC) to $98 from $102 and keeps an Outperform rating on the ...
Trump Win Meaningful For Large Ticket Deals, We Like Evercore Over Moelis
Consider investing in companies like Evercore with exposure to large ticket transactions post-Trump victory, despite caution ...
Meta won't see material impact from tossing fact checking, says Evercore ISI's Mark Mahaney
Mark Mahaney, Evercore ISI head of internet research, joins 'Closing Bell Overtime' to talk announcements from Meta on ...
Zimmer Biomet price target raised to $113 from $110 at Evercore ISI
Evercore ISI raised the firm’s price target on Zimmer Biomet (ZBH) to $113 from $110 and keeps an In Line rating on the ...